We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bausch and Lomb Corporation | TSX:BLCO | Toronto | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
18.50 | 21.98 | 18.97 | 18.12 | 18.95 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices Of Optometrists | USD 4.15B | USD -260M | USD -0.7411 | -25.57 | 6.65B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
20:59:47 | 100 | 18.95 | CAD |
Date | Time | Source | Headline |
---|---|---|---|
08/1/2024 | 12:41 | DJN | Bausch + Lomb Vision-Correction Surgery Platform Approved in U.S. by FDA |
11/9/2023 | 12:58 | DJN | Bausch + Lomb Launches Proposed Financing for Xiidra Acquisition |
06/7/2023 | 18:52 | DJN | Correction to Bausch + Lomb Buys Blink Eye Drop |
06/7/2023 | 12:53 | DJN | Bausch + Lomb Buys Blink Eye Drop From J&J for $106.5 Million |
30/6/2023 | 16:50 | DJN | Bausch + Lomb Shares Climb After $2.5 Billion Deal to Buy Dry-Eye Drug from.. |
Bausch and Lomb (BLCO) Share Charts1 Year Bausch and Lomb Chart |
|
1 Month Bausch and Lomb Chart |
Intraday Bausch and Lomb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions